The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Irbesartan Pharmathen

Pharmathen S.A.EU/1/12/765/001-002

Main Information

Trade NameIrbesartan Pharmathen
Active SubstancesIrbesartan
Dosage FormFilm-coated tablet
Licence HolderPharmathen S.A.
Licence NumberEU/1/12/765/001-002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA04 irbesartan


License statusWithdrawn
Withdrawn Date04/09/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back